Trials / Not Yet Recruiting
Not Yet RecruitingNCT07264959
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
An Observational Study in Patients With Indolent Systemic Mastocytosis
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Blueprint Medicines Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 4, non-interventional, observational study to collect detailed data on the clinical characteristics, clinical outcomes and medical management of ISM in real-world settings. The study will describe the demographic and clinical characteristics of ISM participants, including anaphylaxis and bone manifestations in ISM. Quality of life and disease control will be assessed through participant questionnaires. The study will also evaluate real world ISM treatment management, including use of avapritinib.
Conditions
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2032-12-01
- Completion
- 2032-12-01
- First posted
- 2025-12-04
- Last updated
- 2025-12-04
Source: ClinicalTrials.gov record NCT07264959. Inclusion in this directory is not an endorsement.